Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System
AbstractThis study reviews and evaluates the national drug formulary system used to improve patient access to new drugs by making reimbursement decisions for new drugs as part of the South Korean national health insurance system. The national health insurance utilizes three methods for improving patient access to costly drugs: risk-sharing agreements, designation of essential drugs, and a waiver of cost-effectiveness analysis. Patients want reimbursement for new drugs to be processed quickly to improve their access to these drugs, whereas payers are careful about listing them given the associated financial burden and the uncertainty in cost-effectiveness. However, pharmaceutical companies are advocating for drug prices above certain thresholds to maintain global pricing strategies, cover the costs of drug development, and fund future investments into research and development. The South Korean government is expected to develop policies that will improve patient access to drugs with unmet needs for broadening health insurance coverage. Simultaneously, the designing of post-listing management methods is warranted for effectively managing the financial resources of the national health insurance system. View Full-Text
Share & Cite This Article
Yoo, S.-L.; Kim, D.-J.; Lee, S.-M.; Kang, W.-G.; Kim, S.-Y.; Lee, J.H.; Suh, D.-C. Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System. Int. J. Environ. Res. Public Health 2019, 16, 288.
Yoo S-L, Kim D-J, Lee S-M, Kang W-G, Kim S-Y, Lee JH, Suh D-C. Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System. International Journal of Environmental Research and Public Health. 2019; 16(2):288.Chicago/Turabian Style
Yoo, Seung-Lai; Kim, Dae-Jung; Lee, Seung-Mi; Kang, Won-Gu; Kim, Sang-Yoon; Lee, Jong H.; Suh, Dong-Churl. 2019. "Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System." Int. J. Environ. Res. Public Health 16, no. 2: 288.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.